Home / Insider News / INVO
Insider Buy Cluster Buy CEO Buy June 1, 2022

Shum Steve purchased ~$337K in INVO Bioscience, Inc. stock

INVO Bioscience, Inc. (INVO)  ·  Chief Executive Officer  ·  Data via SEC EDGAR Form 4

Verity Signals Research Published Updated

= insider buy date

90-day return

+1.1%

vs SPY -2.4%

INVO price after insider trade by Shum Steve

Insider

Shum Steve

Role

Chief Executive Officer

Transaction

Open-Market Purchase

Approx. Value

~$337K

Trade Date

Jun 1, 2022

Company

INVO Bioscience, Inc.

Ticker

INVO

Source

SEC EDGAR Form 4

Very Strong conviction signal

Scored in the top tier across multiple factors. Fewer than 5% of insider trades receive this rating.

~$337K purchase

A meaningful investment of personal capital. The average insider purchase is around $150K, putting this in the typical range for serious positions.

Chief Executive Officer

CEOs have the deepest knowledge of company operations. Academic research shows CEO purchases outperform other insider trades by a wide margin.

9 insiders traded in the same window

When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.

+1.1% in 90 days (S&P 500: -2.4%)

This trade beat the S&P 500 by 3.5 percentage points over 90 days. We track performance on every insider trade so you can see who consistently outperforms.

SS

How good is Shum Steve at picking stocks?

Full track record: win rate, average return, and performance vs S&P 500

See track record
9

Shum Steve wasn't the only one buying.

9 insiders at INVO Bioscience, Inc. traded within the same 30-day window.

See who else bought · Free

On June 1, 2022, Shum Steve — Chief Executive Officer of INVO Bioscience, Inc. — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$337K in INVO Bioscience, Inc. (INVO) stock.

This transaction was part of a cluster — 9 insiders at INVO Bioscience, Inc. made open-market purchases within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.

Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.

In the 90 days following this trade, INVO returned +1.1% versus -2.4% for the S&P 500 over the same period.

Full Conviction Analysis

Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.

Upgrade to Trader

Get notified the next time Shum Steve trades

Free alerts · No credit card · Instant notification

Set free alert

All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.

Signal strength Very Strong
Trade size ~$337K
Insider role Chief Executive Officer
Cluster 9 insiders
90-day return +1.1%
vs S&P 500 +3.5%

What is this?

When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.

Why does it matter?

Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.

What makes a trade "strong"?

We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.

Read our full methodology →

Never miss a signal

Get notified when high-conviction insiders buy. Free account, no credit card.

Sign up free